API & INTERMEDIATES
Active Pharmaceutical Ingredients
Therapeutic Area Products Status
Anti-Cancer Irinotecan hydrochloride USP USDMF No. 30516
Anti-Cancer Lenalidomide DMF
Anti-Ulcer Misoprostol 1% dispersion in HPMC Tech pack
Anti Thrombotic Ticagrelor Open Part DMF
Anti-Cancer Topotecan hydrochloride COA and samples
Anti-Cancer Pazopanib Hcl COA and samples
Anti-Cancer Palbociclib R&D
Anti-Cancer Carfilzomib COA
Anti-Cancer Methotrexate R&D
Hematology Eltrombopag olamine R&D
PAH Macitentan R&D
Psoriatic Arthritis Apremilast R&D
Antipsychotic Pimavanserin R&D
Intermediates
Name CAS No.
Irinotecan Intermediates
7-Ethyl-10-hydroxycamptothecin (SN-38) (USDMF No. 27429) 86639-52-3
(s)-8-Ethyl-8-hydroxy-2,3,5,8-tetrahydro-6-oxa-3a-aza-cyclopenta [b]naphthalene-1,4,7-trione 110351-94-5
2-Amino-5-hydroxypropiophenone (AHPP) 35364-15-9
Topotecan Intermediate
10-hydroxycamptothecin (USDMF No. 26025) 19685-09-07
Pazopanib Hcl Intermediate
2,4-dichloropyrimidine 3934-20-1
Ticagrelor Intermediate
2-[[(3aS,4R,6S,6aR)-4-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-2,2-dimethyl-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-6-yl]oxy]ethanol ( N-1 stage) 274693-26-4
Carfilzomib Intermediates
(S)-2-((S)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentan amido)-3-phenyipropanoic acid 868540-16-3
(S)-2-amino-4-methyl-1-((R)-2-methyloxiran-2-yl)pentan-1-one trifluoroacetic acid salt 247068-85-5
Osimertinib Intermediates
4-Fluoro-2-methoxy-5-nitroaniline 1075705-01-9
N-(4-Fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)-2-pyrimidinamine 1421372-94-2
Dapagliflozin and Ertugliflozin Intermediates
(5-bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone 461432-22-4
5-bromo-2-chloro-4'-ethoxydiphenylmethane 461432-23-5
Other Intermediates
Camptothecin 7689-03-4
7-Ethylcamptothecin 78287-27-1
7-Olivetol 500-66-3
Ethyl olivetolate 38862-65-6
3-Oxocyclobutanecarboxylic acid 23761-23-1
6-Hydroxy-1,2,3,4-tetrahydroisoquinoline 14446-24-3
2-Amino-5-bromobenzaldehyde 29124-57-0
2,6-Dimethylmorpholine 141-91-3
Quinoxaline-2-carboxaldehyde 1593-08-4
2-Chloro-1,3,2-dioxaphospholane 2-oxide 6609-64-9
3,4-benzyloxybenzaldehyde 1700-37-4
2-Ethylmorpholine 52769-10-5
4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester 286961-14-6
Beta-glycerophosphate disodiumsalt pentahydrate 13408-09-8
trans-1-Propenylboronic acid pinacol ester 83947-58-4
2-Bromo-1-[4-hydroxy-3 (hydroxymethyl)phenyl]ethan-1-one 62932-94-9
Trimethylsulfoxonium chloride 5034-06-0
Tri-tert-butylphosphonium tetrafluoroborate 131274-22-1
All transactions are carried out in conformity with patent laws applicable in the user country. Responsibility with respect to third party's patent right in a specific country lies exclusively with the buyer. Products currently covered by valid US patents are offered for R&D use in accordance with 35 USC 271 A13(1)